Quantitative medical imaging

Journal of Imaging Science and Technology

Volumn 51, Issue 2, 2007, Pages 117-121

  Ashton, Edward A ^a  

^a VirtualScopics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIALS; CURRENT IMAGING PRACTICES; QUANTITATIVE IMAGING;

CHEMICAL ANALYSIS; DIAGNOSIS; IMAGE ANALYSIS; STANDARDIZATION;

MEDICAL IMAGING;

EID: 34250672824     PISSN: 10623701     EISSN: None     Source Type: Journal    
DOI: 10.2352/J.ImagingSci.Technol.(2007)51:2(117)     Document Type: Article

References (15)

1. P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Van Glabbeke, A. van Oosterom, M. Christian, and S. Gwyther, "New guidelines to evaluate the response to treatment in solid tumors", J. Natl. Cancer Inst. 92, 205 (2000).
2. R. Twombly, "Criticism of tumor response criteria raises trial design questions", J. Natl. Cancer Inst. 98, 232 (2006).
3. R. S. Benjamin, H. Choi, H. Macapinlac, M. Burgess, S. Patel, L. Chen, D. Podoloff, and C. Chuslip, "Response of gastrointestinal stromal tumors (GISTs) to imatinib by Choi criteria and response evaluation criteria in solid tumors (RECIST) as surrogates for survival and time to progression", 2006 ASCO Annual Meeting Proceedings Part I, 9506 (2006).
4. G. Liu, H. Rugo, G. Wilding, T. McShane, J. Evelhoch, C. Ng, E. Jackson, F. Kelcz, B. Yeh, F. Lee, C. Charnsangavej, J. Park, E. Ashton, H. Steinfeldt, Y. Pithavala, S. Reich, and R. Herbst, "Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in Patients with advanced solid tumors: Results from a phase I study", J. Clin. Oncol. 23, 5464 (2005).
5. E. Ashton, T. McShane, and J. Evelhoch, "Inter-operator variability in perfusion assessment of tumors in MRI using automated AIF detection", LNCS 3749, 451 (2005).
6. E. Ashton, C. Takahashi, M. Berg, A. Goodman, S. Totterman, and S. Ekholm, "Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI", J. Magn. Reson. Imaging 17, 300 (2003).
7. K. Van Leemput, F. Maes, D. Vandermeulen, A. Colchester, and P. Suetens, "Automated segmentation of multiple sclerosis lesions by model outlier detection", IEEE Trans. Med. Imaging 20, 677 (2001).
8. S. Galbraith, M. Lodge, N. Taylor, G. Rustin, S. Bentzen, J. Stirling, and A. Padhani, "Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: Comparison of quantitative and semiquantitative analysis", NMR Biomed. 15, 132 (2002).
9. A. Padhani, C. Hayes, S. Landau, and M. Leach, "Reproducibility of quantitative dynamic MRI of normal human tissues", NMR Biomed. 15, 143 (2002).
10. M. Rijpkema, J. Kaanders, F. Joosten, A. van der Kogel, and A. Heerschap, "Method for quantitative mapping of dynamic MRI contrast agent enhancement in human tumors", J. Magn. Reson. Imaging 14, 457 (2001).
11. K. Murase, K. Kikuchi, H. Miki, T. Shimuzu, and J. Ikezoe, "Determination of arterial input function using fuzzy clustering for quantification of cerebral blood flow with dynamic susceptibility contrast-enhanced MR imaging", J. Magn. Reson. Imaging 13, 797 (2001).
12. E. Ashton, L. Molinelli, S. Totterman, and K. Parker, "Evaluation of reproducibility for manual and semi-automated feature extraction in CT and MR images", Proc. IEEE ICIP (IEEE, Piscataway, NJ, 2002) Vol. 3, p. 161.
13. P. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging", J. Magn. Reson Imaging 7, 91 (1997).
14. E. Ashton, J. Riek, L. Molinelli, M. Berg, and K. Parker, "A method for fully automated measurement of neurological structures in MRI", Proc. SPIE 5032, 1125 (2003).
15. E. Ashton, K. Parker, M. Berg, and C. Chen, "A novel volumetric feature extraction technique, with applications to MR images", J. Magn. Reson. Imaging 16, 365 (1997).